Laboratoire de pharmacologie et toxicologie neurocardiovasculaire

(1 - 20 of 103)

Pages

Export to file

Format

Style

Style

Bookmark

	Étiquette
	0145 : Involvement of the sympathetic nervous system in the development of metabolic disorders AUBERTIN-KIRCH, Gaëlle, WEISS, Maud, TRAVERSI, Florian, BOUSQUET, Pascal, MONASSIER, Laurent et NIEDERHOFFER, Nathalie, 2015. 0145 : Involvement of the sympathetic nervous system in the development of metabolic disorders. Archives of Cardiovascular Diseases Supplements [en ligne]. 6 mai 2015. Vol. 7. [Consultésans date]. DOI 10.1016/S1878-6480(15)30024-0. Consulté de : http://www.sciencedirect.com/science/article/pii/S18786480153002401. .
	0260 : Imidazoline I1 receptor ligands activate hepatic adiponectin pathways and thus improve insulin sensitivity WEISS, Maud, BENAMEUR, Djamil, BOUSQUET, Pascal, NIEDERHOFFER, Nathalie et GRENEY, Hugues, 2014. 0260 : Imidazoline I1 receptor ligands activate hepatic adiponectin pathways and thus improve insulin sensitivity. Archives of cardiovascular diseases supplements [en ligne]. avril 2014. Vol. 26. [Consultésans date]. DOI 10.1016/S1878-6480(14)71294-7. Consulté de : http://www.sciencedirect.com/science/article/pii/S18786480147129471. .
	03-P008 : Improvement of insulin sensitivity by imidazoline-like drugs in rats NIEDERHOFFER, Nathalie, BOUCHOUCHA, S., GRENEY, Hugues et BOUSQUET, Pascal, 2012. 03-P008 : Improvement of insulin sensitivity by imidazoline-like drugs in rats. Fundamental and Clinical Pharmacology [en ligne]. 8 avril 2012. Vol. 26, pp. 5-6. [Consultésans date]. DOI 10.1111/j.1472-8206.2012.01032.x. Consulté de : http://onlinelibrary.wiley.com/doi/10.1111/fcp.2012.26.issue-s1/issuetoc1. .
	0321 : Imidazoline-like drug improve insulin sensitivity through a direct stimulation of adiponectin secretion in primary adipocytes WEISS, Maud, TRAVERSI, Florian, BOUSQUET, Pascal, GRENEY, Hugues et NIEDERHOFFER, Nathalie, 2015. 0321 : Imidazoline-like drug improve insulin sensitivity through a direct stimulation of adiponectin secretion in primary adipocytes. Archives of Cardiovascular Diseases Supplements [en ligne]. 6 mai 2015. Vol. 7. [Consultésans date]. DOI 10.1016/S1878-6480(15)30029-X. Consulté de : http://www.sciencedirect.com/science/article/pii/S187864801530029X1. .
	11-02 : Effects of imidazoline-like drugs on insulin sensitivity and adiponectin pathway NIEDERHOFFER, Nathalie, BOUCHOUCHA, S., WEISS, Maud, GRENEY, Hugues et BOUSQUET, Pascal, 2013. 11-02 : Effects of imidazoline-like drugs on insulin sensitivity and adiponectin pathway. Fundamental and Clinical Pharmacology [en ligne]. 25 avril 2013. Vol. 27. [Consultésans date]. DOI 10.1111/fcp.12025. Consulté de : http://onlinelibrary.wiley.com/doi/10.1111/fcp.12025/full1. .
	129 : Cardiac muscarinic receptor overexpression as a possible cause of vagal hyperreactivity LIVOLSI, Angelo, NIEDERHOFFER, Nathalie, DALI-YOUCEF, N., MOKNI, W., OLEXA, C., GIES, J. P., FELDMAN, J. et BOUSQUET, Pascal, 2010. 129 : Cardiac muscarinic receptor overexpression as a possible cause of vagal hyperreactivity. Fundamental and Clinical Pharmacology [en ligne]. 8 mars 2010. Vol. 24, pp. 26-27. [Consultésans date]. DOI 10.1111/j.1472-8206.2010.00819.x. Consulté de : http://onlinelibrary.wiley.com/doi/10.1111/j.1472-8206.2010.00819.x/pdf1. Abstracts of the 14th Annual Meeting of French Society of Pharmacology and Therapeutics, 77th Annual Meeting of Society of Physiology, 31th Pharmacovigilance Meeting, 11th APNET Seminar and 8th CHU CIC Meeting, 23-25 March 2010, Bordeaux, France.
	18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation IMPERIALE, A., RUST, E., GABRIEL, S., DETOUR, J., GOICHOT, Bernard, DUCLOS, B., KURTZ, J. E., BACHELLIER, P., NAMER, I. J. et TAIEB, D., 2014. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation. The Journal of Nuclear Medicine [en ligne]. 2014. Vol. 55, n° 3pp. 367-372. [Consultésans date]. DOI 10.2967/jnumed.113.126896. Consulté de : http://www.ncbi.nlm.nih.gov/pubmed/24343986
	308 : Cardiac muscarinic receptor overexpression in sudden infant death syndrome LIVOLSI, Angelo, NIEDERHOFFER, Nathalie, DALI-YOUCEF, N., RAMBAUD, C., OLEXA, Catherine, MOKNI, W., GIES, Jean-Pierre P. et BOUSQUET, Pascal, 2011. 308 : Cardiac muscarinic receptor overexpression in sudden infant death syndrome. Fundamental and Clinical Pharmacology [en ligne]. 28 mars 2011. Vol. 25. [Consultésans date]. DOI 10.1111/j.1472-8206.2011.00930.x. Consulté de : http://onlinelibrary.wiley.com/doi/10.1111/j.1472-8206.2011.00930.x/pdf1. Abstracts of the 15th Annual Meeting of the French Society of Pharmacology and Therapeutics, the 78th Annual Meeting of the Society of Physiology, the 32nd Pharmacovigilance Meeting, the 12th APNET Seminar and the 9th CHU CIC Meeting, 22-24 March 2011, Grenoble, France.
	Ablation of SGK1 impairs endothelial cell migration and tube formation leading to decreased neo-angiogenesis following myocardial infarction ZARRINPASHNEH, E., POGGIOLI, T., SARATHCHANDRA, P., LEXOW, J., MONASSIER, Laurent, TERRACCIANO, C., LANG, F., DAMILANO, F., ZHOU, J. Q., ROSENZWEIG, A., ROSENTHAL, N. et SANTINI, M. P., 2013. Ablation of SGK1 impairs endothelial cell migration and tube formation leading to decreased neo-angiogenesis following myocardial infarction. PLoS ONE [en ligne]. 2013. Vol. 8, n° 11. [Consultésans date]. DOI 10.1371/journal.pone.0080268. Consulté de : http://www.ncbi.nlm.nih.gov/pubmed/24265802
	Abnormal nociception and opiate sensitivity of STOP null mice exhibiting elevated levels of the endogenous alkaloid morphine. CHARLET, Alexandre, MULLER, Arnaud H, LAUX, Alexis, KEMMEL, Veronique, SCHWEITZER, Annie, DELOULME, Jean-Christophe, STUBER, Denise, DELALANDE, François, BIANCHI, Enrica, VAN DORSSELAER, Alain, AUNIS, Dominique, ANDRIEUX, Annie, POISBEAU, Pierrick et GOUMON, Yannick, 2010. Abnormal nociception and opiate sensitivity of STOP null mice exhibiting elevated levels of the endogenous alkaloid morphine. Molecular pain. 20 décembre 2010. Vol. 6, pp. 96. DOI 10.1186/1744-8069-6-96. 1. journal article. 2. research support, non-u.s. gov't. 3. 2010 Dec 20. 4. 2010 12 20. 5. . 6. imported.
	Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics HRABE DE ANGELIS, M., NICHOLSON, G., SELLOUM, Mohammed, WHITE, J. K., MORGAN, H., RAMIREZ-SOLIS, R., SORG, Tania, WELLS, S., FUCHS, H., FRAY, M., ADAMS, D. J., ADAMS, N. C., ADLER, T., AGUILAR-PIMENTEL, A., ALI-HADJI, Dalila, AMANN, Grégory, ANDRE, Philippe, ATKINS, S., AUBURTIN, Aurélie, AYADI, Abdelkader, BECKER, Julien, BECKER, L., BEDU, Elodie, BEKEREDJIAN, R., BIRLING, Marie-Christine, BLAKE, A., BOTTOMLEY, J., BOWL, M. R., BRAULT, Véronique, BUSCH, D. H., BUSSELL, J. N., CALZADA-WACK, J., CATER, H., CHAMPY, Marie-France, CHARLES, Philippe, CHEVALIER, Claire, CHIANI, F., CODNER, G. F., COMBE, R., COX, R., DALLONEAU, E., DIERICH, A., DI FENZA, A., DOE, B., DUCHON, Arnaud, EICKELBERG, O., ESAPA, C. T., FERTAK, L. E., FEIGEL, T., EMELYANOVA, I., ESTABEL, J., FAVOR, J., FLENNIKEN, A., GAMBADORO, A., GARRETT, L., GATES, H., GERDIN, A. K., GKOUTOS, G., GREENAWAY, S., GLASL, L., GOETZ, P., DA CRUZ, I. G., GOTZ, A., GRAW, J., GUIMOND, Alain, HANS, W., HICKS, G., HOLTER, S. M., HOFLER, H., HANCOCK, J. M., HOEHNDORF, R., HOUGH, T., HOUGHTON, R., HURT, A., IVANDIC, B., JACOBS, Hugues, JACQUOT, Sylvie, JONES, N., KARP, N. A., KATUS, H. A., KITCHEN, S., KLEIN-RODEWALD, T., KLINGENSPOR, M., KLOPSTOCK, T., LALANNE, Valérie, LEBLANC, Sophie, LENGGER, C., LE MARCHAND, Elise, LUDWIG, T., LUX, Aline, MCKERLIE, C., MAIER, H., MANDEL, Jean-Louis, MARSCHALL, S., MARK, Manuel, MELVIN, D. G., MEZIANE, Hamid, MICKLICH, K., MITTELHAUSER, C., MONASSIER, Laurent, MOULAERT, David, MULLER, S., NATON, B., NEFF, F., NOLAN, P. M., NUTTER, L. M., OLLERT, M., PAVLOVIC, Guillaume, PELLEGATA, N. S., PETER, E., PETIT-DEMOULIERE, Benoît, PICKARD, A., PODRINI, C., POTTER, P., POUILLY, Laurent, PUK, O., RICHARDSON, D., ROUSSEAU, Stéphane, QUINTANILLA-FEND, L., QUWAILID, M. M., RACZ, I., RATHKOLB, B., RIET, Fabrice, ROSSANT, J., ROUX, Michel, ROZMAN, J., RYDER, E., SALISBURY, J., SANTOS, L., SCHABLE, K. H., SCHILLER, E., SCHREWE, A., SCHULZ, H., STEINKAMP, R., SIMON, M., STEWART, M., STOGER, C., STOGER, T., SUN, M., SUNTER, D., TEBOUL, L., TILLY, I., TOCCHINI-VALENTINI, G. P., TOST, M., TREISE, I., VASSEUR, Laurent, VELOT, E., VOGT-WEISENHORN, D., WAGNER, Christel, WALLING, A., WATTENHOFER-DONZE, Marie, WEBER, Bruno, WENDLING, Olivia, WESTERBERG, H., WILLERSHAUSER, M., WOLF, E., WOLTER, A., WOOD, J., WURST, W., YILDIRIM, A. O., ZEH, R., ZIMMER, A., ZIMPRICH, A., CONSORTIUM, Eumodic, HOLMES, C., STEEL, K. P., HERAULT, Yann, GAILUS-DURNER, V., MALLON, A. M. et BROWN, S. D., 2015. Analysis of mammalian gene function through broad-based phenotypic screens across a consortium of mouse clinics. Nature Genetics [en ligne]. 27 juillet 2015. Vol. 47, n° 9pp. 969-978. [Consultésans date]. DOI 10.1038/ng.3360. Consulté de : http://www.ncbi.nlm.nih.gov/pubmed/262145911. Comment in : Genetic differential calculus. [Nat Genet. 2015] Comment in : Scaling up phenotyping studies. [Nat Biotechnol. 2015].
	Cardiac muscarinic receptor overexpression as a possible cause of vagal hyperreactivity LIVOLSI, Angelo, NIEDERHOFFER, Nathalie, DALI-YOUCEF, N., MOKNI, W., OLEXA, C., GIES, J. P., FELDMAN, J. et BOUSQUET, Pascal, 2011. Cardiac muscarinic receptor overexpression as a possible cause of vagal hyperreactivity. European Heart Journal [en ligne]. 2011. Vol. 32. [Consultésans date]. Consulté de : http://eurheartj.oxfordjournals.org/content/32/suppl_11. .
	Cardiac muscarinic receptor overexpression in sudden infant death syndrome LIVOLSI, Angelo, NIEDERHOFFER, Nathalie, DALI-YOUCEF, N., RAMBAUD, C., OLEXA, C., MOKNI, W., GIES, J. P. et BOUSQUET, Pascal, 2011. Cardiac muscarinic receptor overexpression in sudden infant death syndrome. European Heart Journal [en ligne]. 2011. Vol. 32. [Consultésans date]. Consulté de : http://eurheartj.oxfordjournals.org/content/32/suppl_11. .
	Cardiac surgery and C1-inhibitor deficiency CHAMARAUX-TRAN, T. N., LEVY, F., ZAPPATERRA, M., GOETZ, J., GOICHOT, Bernard et STEIB, A., 2014. Cardiac surgery and C1-inhibitor deficiency. Journal of cardiothoracic and vascular anesthesia [en ligne]. 2014. Vol. 28, n° 6pp. 1570-1574. [Consultésans date]. DOI 10.1053/j.jvca.2013.05.006. Consulté de : http://www.ncbi.nlm.nih.gov/pubmed/24064203
	Cardiovascular effects of chronic treatment with a beta2-adrenoceptor agonist relieving neuropathic pain in mice CHOUCAIR-JAAFAR, Nadia, BEETZ, N., GILSBACH, R., YALCIN-CHRISTMANN, Ipek, WALTISPERGER, Elisabeth, FREUND, Marie-Jose J., MONASSIER, Laurent, HEIN, L. et BARROT, Michel, 2011. Cardiovascular effects of chronic treatment with a beta2-adrenoceptor agonist relieving neuropathic pain in mice. Neuropharmacology [en ligne]. 23 février 2011. Vol. 61, n° 1pp. 51-60. [Consultésans date]. DOI 10.1016/j.neuropharm.2011.02.015. Consulté de : http://www.sciencedirect.com/science/article/pii/S0028390811000852?via%3Dihub1. .
	CASD 002 : Cardiac muscarinic receptor overexpression in sudden infant death syndrome BOUSQUET, Pascal, LIVOLSI, Angelo, NIEDERHOFFER, Nathalie, OLEXA, Catherine et MOKNI, Walid, 2011. CASD 002 : Cardiac muscarinic receptor overexpression in sudden infant death syndrome. Fundamental and Clinical Pharmacology [en ligne]. 20 octobre 2011. Vol. 25. [Consultésans date]. DOI 10.1111/j.1472-8206.2011.00994.x. Consulté de : http://onlinelibrary.wiley.com/doi/10.1111/j.1472-8206.2011.00994.x/full1. .
	Characterization of the serotonergic system in pathological human cardiac valves AYME-DIETRICH, E., GASSER, Bernard, LAWSON, R., MAZZUCOTELLI, J. P. et MONASSIER, Laurent, 2013. Characterization of the serotonergic system in pathological human cardiac valves. . 2013.
	Chimiothérapies anticancéreuses MONASSIER, Laurent, 2011. Chimiothérapies anticancéreuses. Dans : Cahiers des sciences infirmières - UE 2.11 Pharmacologie et thérapeutiques ; sous l'égide du Collège national des Enseignants de pharmacologie médicale (CNPM) ; sous la coordination de Françoise Goirand et Marc Bardou. pp. 83-102.
	Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters GOICHOT, Bernard, CARON, P., LANDRON, F. et BOUEE, S., 2016. Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters. Clinical Endocrinology [en ligne]. 2016. Vol. 84, n° 3pp. 445-451. [Consultésans date]. DOI 10.1111/cen.12816. Consulté de : http://www.ncbi.nlm.nih.gov/pubmed/25959282
	Clinical presentation (symptoms and complications) of hyperthyroidism in a cohort of 1,144 patients : results of the Thyrdel study GOICHOT, Bernard, BOUÉE, S., NDAYE, N., CARON, P. et LANDRON, F., 2012. Clinical presentation (symptoms and complications) of hyperthyroidism in a cohort of 1,144 patients : results of the Thyrdel study. Endocrine Abstract [en ligne]. 2012. Vol. 29. [Consultésans date]. Consulté de : http://www.endocrine-abstracts.org/ea/0029/ea0029p1629.htm

Pages

Islandora displays